MAP1LC3A and TBC1D9

  • Number of citations of the paper that reports this interaction (PMID 22354992)
  • 16

MAP1LC3A

TBC1D9

Gene Name microtubule-associated protein 1 light chain 3 alpha TBC1 domain family, member 9 (with GRAM domain)
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 40 interactors: AKAP13 APP ATG101 ATG13 ATG3 ATG4B ATG7 BNIP3L DVL2 EPHA7 FAM134C FUNDC1 KIF15 KXD1 MAP1A MAP1S NBR1 OPTN PIAS4 PRPF40A RABGAP1 RABGAP1L RDH12 RTKN SQSTM1 SRPK1 TBC1D1 TBC1D10A TBC1D10B TBC1D16 TBC1D17 TBC1D2 TBC1D25 TBC1D2B TBC1D5 TBC1D7 TBC1D9 TBC1D9B TNIP1 TUBA4A 4 interactors: GABARAPL1 GABARAPL2 MAP1LC3A MAP1LC3B
Entrez ID 84557 23158
HPRD ID 03144 11115
Ensembl ID ENSG00000101460 ENSG00000109436
Uniprot IDs Q9H492 Q6ZT07
PDB IDs 3ECI
Enriched GO Terms of Interacting Partners?
Tagcloud ?
acquiring  adenocarcinoma  autophagy  became  came  constitutive  date  demethylation  egfr  erlotinib  escaping  exposing  gefitinib  ie  immunoreactivity  necessarily  neoplastic  novo  overcoming  parental  pc9  pivotal  predictor  pronounced  restores  tkis  treating  tumoural 
affinities  appeared  carcinomas  companion  diagnostics  differences  egf  er  esr1  female  females  gender  genders  il6st  lrba  male  males  nat1  neu  pathological  pgr  plk1  pr  products  prognosis  rabep1  represents  share  therapeutics 
Tagcloud (Difference) ?
acquiring  adenocarcinoma  autophagy  became  came  constitutive  date  demethylation  egfr  erlotinib  escaping  exposing  gefitinib  ie  immunoreactivity  necessarily  neoplastic  novo  overcoming  parental  pc9  pivotal  predictor  pronounced  restores  tkis  treating  tumoural 
affinities  appeared  carcinomas  companion  diagnostics  differences  egf  er  esr1  female  females  gender  genders  il6st  lrba  male  males  nat1  neu  pathological  pgr  plk1  pr  products  prognosis  rabep1  represents  share  therapeutics 
Tagcloud (Intersection) ?